Development code · Small Molecule
CVL-865
CVL-865 is a development code for Darigabat (CVL-865), developed by Cerevel Therapeutics Holdings, Inc..
- Status
- Discontinued for Epilepsy
- Mechanism
- GABA-A receptor alpha-2 PAM
- Developer
- Cerevel Therapeutics Holdings, Inc.
Programs
- Darigabat (CVL-865) for EpilepsyDiscontinuedDiscontinued
Also known as
- PF-06372865
- darigabat
- 1614245-70-3